Eric Crombez, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 17,890 shares at $42.10 ($753K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Open-market sale of $753k RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.10 | 8,945 | $377K | 50.0% |
| 2 | $42.10 | 8,945 | $377K | 50.0% |
| Total | $42.10 avg | 17,890 | $753K | 100% |
| Filing → |
| RARE | SELL | 2026-03-03 | $160K | — | Filing → |
| ABEO | SELL | 2026-02-02 | $166K | — | Filing → |
| ABEO | SELL | 2025-08-15 | $33K | — | Filing → |